Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
NP001: A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects with Amyotrophic Lateral Sclerosis (ALS) and Evidence of Elevated Systemic Inflammation
Kasarskis, Edward
(PI)
Neuroscience Research Priority Area
Neurology
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
9/12/16
→
9/11/18
Funding
Neuraltus Pharmaceuticals Incorporated:
$148,811.00
View all
View less